1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells (vol 72, pg 1370, 2020)

被引：0
|
作者：
Wang, Lijing
Xu, Xiaobo
Liu, Tong
Wang, Junfang
Shen, Jiwei
Guo, Ming
Wu, Yingliang
Zhai, Xin
Zuo, Daiying
机构：
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2023年 / 75卷 / 05期
关键词：
D O I：
10.1093/jpp/rgad029
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：718 / 718
页数：1
相关论文
共 25 条
  • [1] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells
    Wang, Lijing
    Xu, Xiaobo
    Liu, Tong
    Wang, Junfang
    Shen, Jiwei
    Guo, Ming
    Wu, Yingliang
    Zhai, Xin
    Zuo, Daiying
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (10) : 1370 - 1382
  • [2] 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl) amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells
    Chang, Xing
    Wang, Junfang
    Bian, Jiang
    Liu, Zi
    Guo, Ming
    Li, Zengqiang
    Wu, Yingliang
    Zhai, Xin
    Zuo, Daiying
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 450
  • [3] Discovery of a potent EGFR and ALK dual mutation inhibitor containing N-(3-((4-((2-(cyclopropylsulfinyl)phenyl)amino)pyrimidin-2-yl)amino) phenyl)acrylamide scaffold
    Li, Wei
    Yao, Han
    Gu, Chenxi
    Ren, Yuanyuan
    Liu, Jiadai
    An, Baijiao
    Hu, Wenhao
    Li, Xingshu
    Chan, Albert S. C.
    BIOORGANIC CHEMISTRY, 2022, 129
  • [4] Discovery of N-(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC
    Chen, Yongfei
    Wu, Jiaxin
    Wang, Aoli
    Qi, Ziping
    Jiang, Taoshan
    Chen, Cheng
    Zou, Fengming
    Hu, Chen
    Wang, Wei
    Wu, Hong
    Hu, Zhenquan
    Wang, Wenchao
    Wang, Beilei
    Wang, Li
    Ren, Tao
    Zhang, Shanchun
    Liu, Qingsong
    Liu, Jing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 674 - 697
  • [5] 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells
    Han, Mengting
    Shen, Jiwei
    Wang, Lijing
    Wang, Yu
    Zhai, Xin
    Li, Yao
    Liu, Meiqiao
    Li, Zengqiang
    Zuo, Daiying
    Wu, Yingliang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 284 : 24 - 31
  • [6] 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells (vol 284, pg 24, 2018)
    Han, Mengting
    Shen, Jiwei
    Wang, Lijing
    Wang, Yu
    Zhai, Xin
    Li, Yao
    Liu, Meiqiao
    Gao, Meiqi
    Li, Zengqiang
    Zuo, Daiying
    Wu, Yingliang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 356
  • [7] Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d] imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo
    Gao, Jian
    Yin, Jiacheng
    Li, Shihao
    Jia, Pingting
    Hong, Renjie
    Chen, Jiahui
    Qu, Xinxin
    Zhang, Zihui
    Li, Mengting
    Zhao, Hui
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 281
  • [8] SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL EVALUATION OF NOVEL COMPOUNDS OF 3-((BENZO[D]THIAZOL-2-YLMETHYL)AMINO)-1-(2,5- DIFLUOROBENZOYL)-4-(2-(4-(SUBSTITUTED )PHENYL)HYDRAZONO)-1H- PYRAZOL-5(4H)-ONE
    Kumari, M. Swarna
    Ravindhranath, L. K.
    Babu, K. Sudhakar
    Reddy, K. Ashok vardhan
    HETEROCYCLIC LETTERS, 2018, 8 (04): : 805 - 813
  • [9] Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia
    Wang, Qiang
    Liu, Feiyang
    Qi, Shuang
    Qi, Ziping
    Yan, Xiao-E.
    Wang, Beilei
    Wang, Aoli
    Wang, Wei
    Chen, Cheng
    Liu, Xiaochuan
    Jiang, Zongru
    Hu, Zhenquan
    Wang, Li
    Wang, Wenchao
    Ren, Tao
    Zhang, Shanchun
    Yun, Cai-Hong
    Liu, Qingsong
    Liu, Jing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 366 - 384
  • [10] Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino) pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies
    Tong, Lexian
    Song, Pinrao
    Jiang, Kailong
    Xu, Lei
    Jin, Tingting
    Wang, Peipei
    Hu, Xiaobei
    Fang, Sui
    Gao, Anhui
    Zhou, Yubo
    Liu, Tao
    Li, Jia
    Hu, Yongzhou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 173 : 44 - 62
123